	Anti-VEGF		Macular laser		Dexamethasone
	Visits	Treatments	Visits	Treatments	Visits	Treatments
Mean total visits and treatment visits (per patient)
At 6 months	5.2	3.8	2.3	1.1	3.9	1.3
At 12 months	7.9	5.1	3.2	1.2	5.6	1.5
At 18 months	9.5	5.9	3.8	1.2	6.6	1.7
At 24 months	10.6	6.4	4.2	1.2	7.2	1.7
At 36 months	11.7	6.9	4.6	1.2	7.8	1.7
Treatment switching (%)
To anti-VEGF	–		80 (12.6)		285 (42.2)
To macular laser	267 (6.8)		–		63 (9.3)
To dexamethasone	162 (4.1)		83 (13.0)		–

anti-VEGF, anti-vascular endothelial growth factor.